Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Finished Drug Prices
NA
1. (1,1'-biphenyl)-3-carboxamide, N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-5-(ethyl(tetrahydro-2h-pyran-4-yl)amino)-4-methyl-4'-(4-morpholinylmethyl)-, Hydrobromide (1:2)
2. (1,1'-biphenyl)-3-carboxamide, N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-5-(ethyl(tetrahydro-2h-pyran-4-yl)amino)-4-methyl-4'-(4-morpholinylmethyl)-, Hydrochloride (1:1)
3. E 7438
4. E-7438 Hydrobromide
5. E7438
6. Epz-6438
7. Epz-6438 Dihydrobromide
8. Epz-6438 Monohydrobromide
9. Epz-6438 Monohydrochloride
10. Epz-6438 Trihydrochloride
11. Ez-438
12. Ez438
13. N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(oxan-4-yl)amino)-4-methyl-4'-((morpholin-4-yl)methyl)(1,1'-biphenyl)-3-carboxamide
14. N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(oxan-4-yl)amino)-4-methyl-4'-((morpholin-4-yl)methyl)(1,1'-biphenyl)-3-carboxamide Monohydrobromide
15. Tazemetostat
16. Tazemetostat Dihydrobromide
17. Tazemetostat Hydrochloride
18. Tazemetostat Monohydrobromide
19. Tazemetostat Monohydrochloride
20. Tazemetostat Trihydrochloride
21. Tazverik
1. 1467052-75-0
2. Tazemetostat Monohydrobromide
3. Epz-6438 Monohydrobromide
4. E-7438 Hydrobromide
5. Ez438
6. Tazemetostat (hydrobromide)
7. Epz-6438 Hydrobromide
8. Tazemetostat Hydrobromide [usan]
9. Tazverik
10. Ez-438
11. 6p89t5m073
12. (1,1'-biphenyl)-3-carboxamide, N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-5-(ethyl(tetrahydro-2h-pyran-4-yl)amino)-4-methyl-4'-(4-morpholinylmethyl)-, Hydrobromide (1:1)
13. N-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide;hydrobromide
14. Unii-6p89t5m073
15. Tazverik (tn)
16. 1467052-77-2
17. Chembl4594260
18. Schembl15313373
19. Dtxsid101027715
20. Hy-13803c
21. Tazemetostat Hydrobromide (jan/usan)
22. Tazemetostat Hydrobromide [jan]
23. Tazemetostat Hydrobromide [who-dd]
24. Epz-6438 Hydrobromide; Tazemetostat Hbr
25. Cs-0101826
26. D11485
27. Tazemetostat Hydrobromide [orange Book]
28. Q27265267
29. N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(oxan-4-yl)amino)-4-methyl-4'-((morpholin-4-yl)methyl)(1,1'-biphenyl)-3-carboxamide Monohydrobromide
30. N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2h-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide Hydrobromide
31. N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2h-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamidehydrobromide
Molecular Weight | 653.6 g/mol |
---|---|
Molecular Formula | C34H45BrN4O4 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 9 |
Exact Mass | 652.26242 g/mol |
Monoisotopic Mass | 652.26242 g/mol |
Topological Polar Surface Area | 83.1 Ų |
Heavy Atom Count | 43 |
Formal Charge | 0 |
Complexity | 992 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
NDC Package Code : 50384-4000
Start Marketing Date : 2020-01-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (160kg/160kg)
Marketing Category : BULK INGREDIENT
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 29943-42-8
End Use API : Tazemetostat
About The Company : MINAKEM is a cGMP custom manufacturer of small molecule API, HPAPI and steroids. All development and manufacturing activities are supported by highly skilled R&...
5-Bromo -2-methyl-3- nitrobenzoic acid
CAS Number : 107650-20-4
End Use API : Tazemetostat
About The Company : Saflik Pharma is a registered company that was started with the aim of providing top notch quality of pharmaceutical API’s and Intermediates to our buyers. We...
Global Sales Information
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?